drugset / Trial / NCT04977193
A Study to Evaluate the Safety and Efficacy of ly011 Cell Injection in the Treatment of Advanced Gastric Adenocarcinoma
Phase 0
Unknown
18 enrolled
Shanghai Longyao Biotechnology Inc., Ltd.
The Affiliated Hospital of Xuzhou Medical University · collab
NaSingle-groupOpen-labelTreatment
Summary
Objective to evaluate the safety and efficacy of ly011 cell injection in the treatment of advanced gastric adenocarcinoma.
Timeline
- Start
- 2021-11-01
- Primary completion
- 2023-05-01
- Completion
- 2024-11-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LY011 | Cell therapy | — | — |